ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Mitesco to Host Shareholder Update Webcast/Conference Call March 8 at 4:15 p.m. Eastern

MINNEAPOLIS, MN - (NewMediaWire) - March 03, 2022 - Mitesco, Inc. (OTCQB: MITI), a leading operator of wellness clinics that combine a nurse practitioner model with personalized, whole-person primary care, will host a shareholder update conference call Tuesday, March 8, 2022, at 4:15 p.m. Eastern Time. The call, which will feature a presentation by CEO Larry Diamond of the company’s newly updated investor PowerPoint, will include a discussion of Mitesco’s significant progress on its expansion plans, plans to uplist the company’s common stock to Nasdaq, growth in the activity level of its existing clinics, and other developments. The presentation will be followed by a question-and-answer session, which can be accessed via the webcast link or dial-in numbers below.

To view the PowerPoint and presentation and participate live over the webcast link, please go to: https://www.webcaster4.com/Webcast/Page/2848/44800

If unable to view the webcast, you may participate via teleconference by dialing in five to ten minutes before the call: (Toll Free) 888-506-0062 domestically, or 973-528-0011 internationally. Entry code:  264574.

The teleconference replay will be available shortly after the completion of the live event through 4:15 pm Eastern time on March 22, 2022. You may access the replay by dialing (Toll Free) 877-481-4010 domestically, or 919-882-2331 internationally, and referencing conference ID 44800.

You may also access the replay by visiting the company's website: www.mitescoinc.com. The site also includes a company overview, links to research, video interviews with management, and contact information.

“There is a Form S-1A Registration Statement filed and available for review on the SEC Edgar website (https://www.sec.gov/ix?doc=/Archives/edgar/data/802257/000118518522000159/miti-20210930.htm), and I encourage all interested parties to review the information prior to this call,” said Mr. Diamond. “Further, we will be attending a number of investor conferences in the near-term, and through press releases will continue to update our shareholders on new developments as they occur.” 

About Mitesco, Inc. and The Good Clinic, LLC

Mitesco is building a next-generation healthcare solution, providing healthcare services and technology, to make healthcare more accessible, higher quality, and more affordable. The Mitesco team has extensive experience in building successful growth situations within the healthcare industry, using both organic and acquisition growth strategies. Mitesco embraces that when consumers’ expectations are exceeded the business performance does so as well. Mitesco operations and subsidiaries include The Good Clinic, LLC (“The Good Clinic”) and Acelerar Healthcare Holdings Limited. The Good Clinic (www.thegoodclinic.com) is a wholly owned subsidiary of Mitesco N.A. LLC, the holding company for North American operations. The Good Clinic is building out a network of clinics using the latest telehealth technology with the certified nurse practitioner operating as its primary healthcare provider. The executive team at The Good Clinic includes several of the key executives who brought Minute ClinicTM (previously known as Quickmedix) to scale, which was acquired by CVS in 2006.

Contacts:

Investor Relations
Jimmy Caplan
512-329-9505
Email: jimmycaplan@me.com

Media Relations
Rick Eisenberg
917-691-8934
Email: eiscom@msn.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.34
+3.03 (1.31%)
AAPL  248.35
+0.70 (0.28%)
AMD  253.73
+3.93 (1.57%)
BAC  52.45
+0.38 (0.73%)
GOOG  330.84
+2.46 (0.75%)
META  647.63
+34.67 (5.66%)
MSFT  451.14
+7.03 (1.58%)
NVDA  184.84
+1.52 (0.83%)
ORCL  178.18
+4.30 (2.47%)
TSLA  449.36
+17.92 (4.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.